Illustration: Sarah Grillo/Axios

There are 3 broad groups of on-demand economy workers, according to Alexandrea Ravenelle, who interviewed some 80 workers for her book, Hustle and Gig: Struggling and Surviving in the Sharing Economy.

Details: The groups are: Strugglers, down on their luck; perhaps they find themselves unable to put their expensive college degrees to use; Strivers, supplementing their salaries and trying to get one rung higher on the economic ladder; Success Stories, who see entrepreneurial opportunity.

What they're saying: For Mark Ferguson, delivering food orders for DoorDash was a means to an end shortly after getting separated and needing extra cash — but he tells Axios it's "not a career" and "there's no ladder to climb."

"On one hand, I do kind of enjoy the change of pace from the typical email and spreadsheets and the 3pm marketing meeting... [But] if you think this is a full-time job and you can make it -- you're fooling yourself. These platforms are here to make money and they will find out the absolute bottom before workers don't show up."

The bottom line: "Even though it's marketed as the height of advancement and app-driven modernity," writes Ravenelle, "for many, gig work is what happens when there are no other options."

Go deeper:

Go deeper

FBI director says China aims to become "world's only superpower"

FBI Director Christopher Wray speaks to the media during a news conference at FBI Headquarters on June 14, 2018 in Washington, DC. Photo: Mark Wilson/Getty Images

FBI Director Christopher Wray gave a speech today at the Hudson Institute in Washington, D.C. in which he laid out "more detail on the Chinese threat than the FBI has ever presented in an open forum."

Why it matters: China's increasingly aggressive behavior under General Secretary Xi Jinping is ringing alarm bells in the U.S.

19 mins ago - Health

Trump administration invests $2 billion in coronavirus drugs

A Novavax researcher prepares to test the vaccine. Photo: Andrew Caballero-Reynolds/AFP via Getty Images

The Department of Health and Human Services and Department of Defense have awarded $1.6 billion to Novavax and $450 million to Regeneron Pharmaceuticals as part of the federal government's efforts to speed up the development of coronavirus treatments.

The bottom line: Federal scientists are holding out hope that these companies' treatments, along with other vaccines in development, will snuff out the spread of the coronavirus.

Breaking down the PPP disclosure debacle

Illustration: Eniola Odetunde/Axios

The U.S. Treasury Department Monday morning released the names over 660,000 small businesses that received Paycheck Protection Program loans of at least $150,000, per its recent compromise with Congress. Well, at least that's what we thought Treasury did.

What happened: Within hours, several well-known companies and investment firms on the list denied that they had ever applied for PPP loans, let alone received them.